过敏性鼻炎:现状及挑战 干细胞纠正免疫失衡,根源性治疗过敏性鼻炎 干细胞治疗过敏性鼻炎的临床进展
参考文献:
[1] 张彭,谢洋,关佳瑞.过敏性鼻炎患者报告结局评价量表的现状与思考[J].中医杂志,2021,62(22):1944-1951.
https://kns.cnki.net/kns8/defaultresult/index
[2] 任振勇,潘万旗.过敏性鼻炎治疗思路探讨[J].山西中医,2021,37(11):1-3.
https://kns.cnki.net/kns8/defaultresult/index
[3] Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011 Dec 17;378(9809):2112-22.
https://pubmed.ncbi.nlm.nih.gov/21783242/
[4] Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, LeClair L, Poynter ME, Steele C, Rincon M, Weiss DJ. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells. 2011 Jul;29(7):1137-48.
https://pubmed.ncbi.nlm.nih.gov/21544902/
[5] Zhao N, Liu Y, Liang H, Jiang X. Bone marrow-derived mesenchymal stem cells reduce immune reaction in a mouse model of allergic rhinitis. Am J Transl Res. 2016 Dec 15;8(12):5628-5636.
https://pubmed.ncbi.nlm.nih.gov/28078033/
[6] Fu QL, Chow YY, Sun SJ, Zeng QX, Li HB, Shi JB, Sun YQ, Wen W, Tse HF, Lian Q, Xu G. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy. 2012 Oct;67(10):1215-22.
https://pubmed.ncbi.nlm.nih.gov/22882409/
[7] Fan XL, Zeng QX, Li X, Li CL, Xu ZB, Deng XQ, Shi J, Chen D, Zheng SG, Fu QL. Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients. Stem Cell Res Ther. 2018 Jun 19;9(1):170.
https://pubmed.ncbi.nlm.nih.gov/29921316/
编辑:小果果,转载请注明出处:https://www.cells88.com/cells/gxb/7414.html
免责声明:本站所转载文章来源于其他平台,主要目的在于分享行业相关知识,传递当前最新资讯。图片、文章版权均属于原作者所有,如有侵权,请及时告知,我们会在24小时内删除相关信息。
说明:本站所发布的案例均摘录于文献,仅用于科普干细胞与再生医学相关知识,不作为医疗建议。